ckd-348
Small moleculeexperimental
Clinical trial activity
10 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
10
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 4, 2019 (NCT04272502)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06112678 | Phase 1 | Dec 7, 2023 | Chong Kun Dang Pharmaceutical |
| NCT05749861 | Phase 1 | Mar 23, 2023 | Chong Kun Dang Pharmaceutical |
| NCT05549401 | Phase 1 | Sep 23, 2022 | Chong Kun Dang Pharmaceutical |
| NCT05192356 | Phase 1 | Jan 26, 2022 | Chong Kun Dang Pharmaceutical |
| NCT04883658 | Phase 1 | May 4, 2021 | Chong Kun Dang Pharmaceutical, Yangji Hospital |
| NCT04660370 | Phase 1 | Dec 9, 2020 | Chong Kun Dang Pharmaceutical, H Plus Yangji Hospital |
| NCT04587206 | Phase 1 | Oct 15, 2020 | Chong Kun Dang Pharmaceutical |
| NCT04258865 | Phase 1 | Feb 13, 2020 | Chong Kun Dang Pharmaceutical, Yangji Hospital |
| NCT04304547 | Phase 1 | Feb 4, 2020 | Chong Kun Dang Pharmaceutical, Seoul National University |
| NCT04272502 | Phase 1 | Jun 4, 2019 | Chong Kun Dang Pharmaceutical, Seoul National University |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chong Kun Dang Pharmaceutical | For profit | 10 | 10 | 1 | 2019 |
| Seoul National University | Academic/Hospital | 2 | 0 | 1 | 2019 |
| Yangji Hospital | Academic/Hospital | 2 | 0 | 1 | 2020 |
| H Plus Yangji Hospital | Academic/Hospital | 1 | 0 | 1 | 2020 |
4 organizations
Page 1 / 1